Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NKTCL”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableNot Yet RecruitingNCT07409168
What this trial is testing

Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Sun Yat-sen University 100
Early research (Phase 1)Looking for participantsNCT06793956
What this trial is testing

Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Extranodal Natural Killer/T Cell Lymphoma
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Looking for participantsNCT06966154
What this trial is testing

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL

Who this might be right for
Natural Killer/T-cell LymphomaRelapsed or Refractory Lymphoma Including ENKL
Fudan University 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573138
What this trial is testing

Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Ruijin Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT04509466
What this trial is testing

Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 41
Testing effectiveness (Phase 2)Looking for participantsNCT07525466
What this trial is testing

Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

Who this might be right for
Extranodal NK T Cell LymphomaHemophagocytic Lymphohistiocytosis (HLH)
Beijing Tongren Hospital 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574528
What this trial is testing

A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma

Who this might be right for
NKTCL
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07615283
What this trial is testing

Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T Cell LymphomaNKTCL
Sun Yat-sen University 40
Large-scale testing (Phase 3)UnknownNCT02085655
What this trial is testing

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Huiqiang Huang 264
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07502768
What this trial is testing

Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma

Who this might be right for
Extranodal NK/T-cell LymphomaNK/T-cell LymphomaRelapsed or Refractory NK/T-Cell Lymphoma
Rong Tao 107
Testing effectiveness (Phase 2)Looking for participantsNCT07380984
What this trial is testing

PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Ruijin Hospital 47
Testing effectiveness (Phase 2)Study completedNCT02927925
What this trial is testing

Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type

Who this might be right for
Lymphoma
Janssen Research & Development, LLC 32
Testing effectiveness (Phase 2)Looking for participantsNCT06559553
What this trial is testing

"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL

Who this might be right for
NKTCLSelinexor
Mingzhi Zhang 50
Testing effectiveness (Phase 2)Ended earlyNCT01948180
What this trial is testing

Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-CellEBV
Cell Medica Ltd 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573151
What this trial is testing

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

Who this might be right for
Lymphoma
Ruijin Hospital 28